APA
Smyth-Medina R., Johnston J., Devries D. K., Jasper A., Kannarr S. R., Schechter B. A., Shen Lee B., Varghese G., Ogundele A., Darby C. H., Karpecki P. & Luchs J. (20200617). Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials. : Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
Chicago
Smyth-Medina Robert, Johnston Josh, Devries Douglas K, Jasper April, Kannarr Shane R, Schechter Barry A, Shen Lee Bridgitte, Varghese George, Ogundele Abayomi, Darby Charles H, Karpecki Paul and Luchs Jodi. 20200617. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials. : Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
Harvard
Smyth-Medina R., Johnston J., Devries D. K., Jasper A., Kannarr S. R., Schechter B. A., Shen Lee B., Varghese G., Ogundele A., Darby C. H., Karpecki P. and Luchs J. (20200617). Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials. : Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
MLA
Smyth-Medina Robert, Johnston Josh, Devries Douglas K, Jasper April, Kannarr Shane R, Schechter Barry A, Shen Lee Bridgitte, Varghese George, Ogundele Abayomi, Darby Charles H, Karpecki Paul and Luchs Jodi. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials. : Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 20200617.